pathogen-specific aAPC

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namepathogen-specific aAPC
Drug Alias Nameuniversal SARS-CoV-2 antigen expressing presenting cell vaccine(Shenzhen Geno-Immune Medical Institute)universal SARS-CoV-2 antigen expressing presenting cell vaccine (Shenzhen Geno-Immune Medical Institute)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen Geno-Immune Medical Institute
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Geno-Immune Medical Institute
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A